Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Last Updated: December 23rd, 2025
Welcome to Collabrity Report (“we,” “us,” “our”). These Terms of Use (“Terms”) govern your use of the Collabrity Report website located at collabrityreport.com and any associated services (collectively, the “Service”). By accessing or using the Service, you agree to these Terms.
By using the Service, you agree to be bound by these Terms, the Privacy Policy, and any other legal notices or conditions posted for specific features of the Service. If you do not agree, you must discontinue use immediately.
We reserve the right to modify or update these Terms at any time. The revised Terms will be effective when posted on the Service with an updated effective date. Continued use of the Service after posting constitutes acceptance of the changes.
You agree to use the Service in compliance with all applicable laws. You may not use the Service to:
• Post unlawful, defamatory, infringing, abusive, or harmful content.
• Disrupt or interfere with the Service or other users’ access.
• Harvest or collect information about others without consent.
If the Service includes forums, comments, or other interactive areas:
• You retain ownership of rights in your user-generated content.
• By posting content, you grant us a non-exclusive, royalty-free, worldwide license to use, modify, and distribute it in connection with the Service.
• We may remove content at our discretion.
All content on the Service—text, graphics, logos, software, and information—is owned or licensed by Collabrity and protected by intellectual property laws. You may not use, reproduce, or distribute this content without permission.
THE SERVICE IS PROVIDED “AS IS” AND “AS AVAILABLE,” WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. We do not guarantee the accuracy, timeliness, or completeness of any content.
To the fullest extent permitted by law, Collabrity and its partners are not liable for any indirect, incidental, special, or consequential damages arising from your use of the Service.
You agree to indemnify and hold harmless Collabrity, its affiliates, and their respective officers, directors, employees, and agents from any claims, losses, or expenses arising out of:
• Your use of the Service
• Violation of these Terms
• Infringement of intellectual property or other rights
These Terms are governed by the laws of the State of Wyoming and applicable federal law. You agree that disputes will be heard exclusively in courts located in Wyoming, unless otherwise required by applicable law.
We may suspend or terminate your access at any time for any reason.
For questions about these Terms, you may contact us via our Contact Us page
These Terms constitute the entire agreement between you and Collabrity regarding the Service and supersede all prior communications.
If any part of these Terms is unenforceable, the remainder will continue in effect.
Collabrity Report 2025 – 2026,
All Rights Reserved
Please note that we exclusively feature news related to Biotech Financing.
Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity is not a registered broker-dealer, and Finalis Securities LLC and Collabrity are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)
collabrityreport.com (the “Collabrity Report Website”) is a website operated by Collabrity. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Collabrity along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.
Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.